| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.24 | 1e-06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.2 | 4e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.19 | 4e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.19 | 8e-08 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |